AI-generated analysis. Always verify with the original filing.
Voyager Therapeutics announced the resignation of Chief Medical Officer Toby Ferguson, M.D., Ph.D., effective February 20, 2026, to pursue a new opportunity, with no disagreement cited. President and CEO Alfred W. Sandrock, Jr., M.D., Ph.D. will assume key clinical development responsibilities on an interim basis following the resignation.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation o
Other Events. Alfred W. Sandrock, Jr., M.D., Ph.D., the Company’s current President and Chief Executive Officer, has agreed to assume key responsibilities, incl
Toby Ferguson, M.D., Ph.D.
Effective: 2026-02-20
To pursue a new opportunity